GSK (GSK)
50.76
-0.02 (0.04%)
Upcoming Events
Latest Headlines
FDA approves GSK lung cancer drug Jideytro ahead of schedule
July 22, 2026 2:00 PM - StreetInsider
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
July 22, 2026 1:59 PM - PR NewsWire
Form 6-K GSK plc For: Jul 22
July 22, 2026 12:52 PM - SEC Filing
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026
July 21, 2026 4:00 AM - BizWire
Form 6-K GSK plc For: Jul 20
July 20, 2026 10:13 AM - SEC Filing
Form 6-K GSK plc For: Jul 17
July 17, 2026 7:14 AM - SEC Filing
GSK halts camlipixant development for chronic cough after mixed results
July 17, 2026 6:55 AM - StreetInsider
Form 6-K GSK plc For: Jul 17
July 17, 2026 6:50 AM - SEC Filing
Form 6-K GSK plc For: Jul 16
July 16, 2026 10:46 AM - SEC Filing
Form 6-K GSK plc For: Jul 15
July 15, 2026 9:12 AM - SEC Filing
Form 6-K GSK plc For: Jul 14
July 14, 2026 11:20 AM - SEC Filing
Form 6-K GSK plc For: Jul 13
July 13, 2026 11:28 AM - SEC Filing
Form 6-K GSK plc For: Jul 13
July 13, 2026 6:29 AM - SEC Filing
Form 6-K GSK plc For: Jul 10
July 10, 2026 8:13 AM - SEC Filing
Form 6-K GSK plc For: Jul 09
July 9, 2026 11:28 AM - SEC Filing
Form 6-K GSK plc For: Jul 09
July 9, 2026 7:28 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19.50 at Deutsche Bank
July 9, 2026 4:59 AM - StreetInsider
GSK terminates collaboration with Alector after trial failures
July 8, 2026 4:13 PM - StreetInsider
HSBC Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Hold
July 6, 2026 1:32 AM - StreetInsider
Form 6-K GSK plc For: Jul 01
July 1, 2026 10:02 AM - SEC Filing
Increasing unusual put option volume: MDLN GSK KVYO BIRK CPRT CIA APD CTSH DT SWKS
June 30, 2026 6:11 AM - StreetInsider
Form 6-K GSK plc For: Jun 29
June 29, 2026 10:26 AM - SEC Filing
Form 6-K GSK plc For: Jun 29
June 29, 2026 10:21 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19 at Barclays
June 29, 2026 4:15 AM - StreetInsider
Form 6-K GSK plc For: Jun 26
June 26, 2026 10:02 AM - SEC Filing
Form 6-K GSK plc For: Jun 24
June 24, 2026 10:46 AM - SEC Filing
Form 6-K GSK plc For: Jun 24
June 24, 2026 10:40 AM - SEC Filing
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026 8:30 AM - StreetInsider
Form 6-K GSK plc For: Jun 23
June 23, 2026 11:05 AM - SEC Filing
Form 6-K GSK plc For: Jun 22
June 22, 2026 11:01 AM - SEC Filing
FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
June 17, 2026 4:21 PM - StreetInsider
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026 4:21 PM - BizWire
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026 12:36 PM - Globe NewsWire
Form 11-K GSK plc For: Dec 31
June 17, 2026 12:21 PM - SEC Filing
Form 11-K GSK plc For: Dec 31
June 17, 2026 12:05 PM - SEC Filing
Form 6-K GSK plc For: Jun 17
June 17, 2026 12:02 PM - SEC Filing
GSK receives FDA approval for oral antibiotic to treat UTIs
June 17, 2026 11:09 AM - StreetInsider
Form 6-K GSK plc For: Jun 15
June 15, 2026 10:02 AM - SEC Filing
German government to drop variable drug discounting plans - Reuters
June 15, 2026 6:08 AM - StreetInsider
Form 6-K GSK plc For: Jun 12
June 12, 2026 6:33 AM - SEC Filing
Form 6-K GSK plc For: Jun 11
June 11, 2026 10:42 AM - SEC Filing
Form 6-K GSK plc For: Jun 10
June 10, 2026 10:37 AM - SEC Filing
Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
June 10, 2026 5:19 AM - StreetInsider
Form 6-K GSK plc For: Jun 09
June 9, 2026 1:37 PM - SEC Filing
Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates
June 9, 2026 9:44 AM - StreetInsider
Form 6-K GSK plc For: Jun 09
June 9, 2026 6:19 AM - SEC Filing
GSK (GSK) call put ratio 1 call to 3.5 with a focus on June 50 puts active
June 9, 2026 5:14 AM - StreetInsider
GSK (GSK) In Talks To Buy Biotech Nuvalent For More Than $9 bln- FT
June 8, 2026 9:06 PM - StreetInsider
Form 6-K GSK plc For: Jun 08
June 8, 2026 4:09 PM - SEC Filing
Form 6-K GSK plc For: Jun 01
June 1, 2026 10:46 AM - SEC Filing
Form 6-K GSK plc For: Jun 01
June 1, 2026 10:00 AM - SEC Filing
PrEP Wisdom: ViiV Healthcare Launches New Campaign to Support Informed HIV Prevention Choices
June 1, 2026 8:00 AM - BizWire
Form 6-K GSK plc For: May 28
May 28, 2026 6:06 AM - SEC Filing
Form 6-K GSK plc For: May 27
May 27, 2026 10:34 AM - SEC Filing
Form SD GSK plc
May 26, 2026 4:22 PM - SEC Filing
Form 6-K GSK plc For: May 26
May 26, 2026 10:24 AM - SEC Filing
Form 6-K GSK plc For: May 26
May 26, 2026 10:17 AM - SEC Filing
Kepler Cheuvreux Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy
May 26, 2026 3:55 AM - StreetInsider
Form 6-K GSK plc For: May 22
May 22, 2026 7:19 AM - SEC Filing
Form 6-K GSK plc For: May 20
May 20, 2026 10:41 AM - SEC Filing
Form 6-K GSK plc For: May 20
May 20, 2026 10:39 AM - SEC Filing
Form 6-K GSK plc For: May 19
May 19, 2026 11:01 AM - SEC Filing
Form 6-K GSK plc For: May 18
May 18, 2026 11:04 AM - SEC Filing
Form 6-K GSK plc For: May 18
May 18, 2026 6:30 AM - SEC Filing
Form 13F-HR GSK plc For: Mar 31
May 14, 2026 4:46 PM - SEC Filing
Form 6-K GSK plc For: May 14
May 14, 2026 12:23 PM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP25 at Jefferies
May 14, 2026 4:13 AM - StreetInsider
This European pharma company's next three months are catalyst-rich: Bernstein
May 14, 2026 2:30 AM - StreetInsider
Form 6-K GSK plc For: May 11
May 11, 2026 10:59 AM - SEC Filing
Form 6-K GSK plc For: May 11
May 11, 2026 6:43 AM - SEC Filing
Form 6-K GSK plc For: May 11
May 11, 2026 6:31 AM - SEC Filing
Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
May 7, 2026 8:00 AM - BizWire
Form 6-K GSK plc For: May 06
May 6, 2026 1:52 PM - SEC Filing
Form SCHEDULE 13G GSK plc Filed by: FMR LLC
May 6, 2026 11:19 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP21 at Citi
May 6, 2026 5:35 AM - StreetInsider
Form 6-K GSK plc For: May 05
May 5, 2026 12:54 PM - SEC Filing
Form 6-K GSK plc For: May 01
May 1, 2026 11:11 AM - SEC Filing
Form 6-K GSK plc For: May 01
May 1, 2026 11:09 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP18 at Barclays
April 30, 2026 5:45 AM - StreetInsider
Form 6-K GSK plc For: Apr 29
April 29, 2026 12:01 PM - SEC Filing
Form 6-K GSK plc For: Apr 29
April 29, 2026 8:10 AM - SEC Filing
The Fifth International Healthcare Week set for next month
April 29, 2026 4:59 AM - StreetInsider
Increasing unusual call option volume: KOPN ERAS OGN FEZ VAL SANM GSK RMBS
April 29, 2026 4:30 AM - StreetInsider
GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.47
April 29, 2026 3:24 AM - StreetInsider
GSK (GSK) spreader of 18K contracts of May 56 calls, 12K contracts of May 60 calls and 12K contracts of May 51 puts
April 28, 2026 2:58 PM - StreetInsider
GSK (GSK) spreader of 18K contracts of May 56 calls, 12K contracts of May 60 calls and 12K contracts of May 51 puts
April 28, 2026 2:46 PM - StreetInsider
Form 6-K GSK plc For: Apr 28
April 28, 2026 11:19 AM - SEC Filing
Form 6-K GSK plc For: Apr 28
April 28, 2026 7:24 AM - SEC Filing
Form 6-K GSK plc For: Apr 27
April 27, 2026 8:13 AM - SEC Filing
Form 6-K GSK plc For: Apr 27
April 27, 2026 6:59 AM - SEC Filing
Form 6-K GSK plc For: Apr 24
April 24, 2026 11:20 AM - SEC Filing
Form 6-K GSK plc For: Apr 23
April 23, 2026 6:05 AM - SEC Filing
Full Article List
